主页文献库搜索
6PPD-quinone exposure and Alzheimer's disease: insights from integrative netw...

Zhang(C),Zhang(J) Open Med (Wars) 2026-01-00

...PIK3CA as key hub genes enriched in the cerebral cortex and basal ganglia. Transcriptomic data confirmed differential ex...

Feasibility of PIK3CA Mutation Detection via Microfluidic Isolation of Dissem...

Grollmann(H),Volz(B),Schroth(W),Bahlinger(... Geburtshilfe Frauenheilkd 2026-05-00

...PIK3CA mutation analysis via MassARRAY PIK3CA Breast Panel and digital droplet PCR. PIK3CA mutations were detected in 42...

Prognostic significance of ctDNA mutations in advanced HER2-positive breast c...

Lin(J),Xu(H),Zhou(Y),Sa(Q),Wang(J),Xu(B) Adv Clin Exp Med 2026-06-00

...PIK3CA mutations correlated with worse PFS (HR = 2.12, 95% CI: 1.43-3.15, p = 0.002), whereas ERBB2 mutations showed no ...

Sequential CRISPR-EspCas9-Mediated Wild-Type Depletion Enhances the Detection...

Hong(S),Park(CS),Been(KW),Kang(S),Hong(J),... Biosensors (Basel) 2026-06-10

...PIK3CA H1047R mutations that were undetectable by conventional Sanger sequencing. To evaluate detection sensitivity, we ...

Whole genome copy number variation analysis to detect genomic regions for res...

Jawad(H),Osonowo(O),Gilleard(JS),Thompson(... BMC Genomics 2026-06-16

...PIK3CA and AGXT duplications, with an enrichment of pathways associated with diabetic cardiomyopathy and prion disease. ...

FUCA2 Sustains AKT Signaling and Suppresses Senescence by Antagonizing FUT3-M...

Chen(L),Guo(J),Li(F),Gao(M),Li(R),Huang(Z)... Adv Sci (Weinh) 2026-08-00

...PIK3CA/AKT1/PTEN mutation(s), induced senescence selectively in FUCA2-high LUAD irrespective of PIK3CA/AKT1/PTEN/TP53 mu...

Deciphering the molecular heterogeneity of HER2-positive breast cancer: the c...

Sengul(I),Sengul(D),Akalin(C) Amino Acids 2026-06-16

...PIK3CA persist across both cohorts, the unique metabolic and immunological milieus confirm that these subtypes represent...

Budget impact analysis of capivasertib as a second-line therapy for advanced ...

Nguyen(T),Mital(S) Expert Rev Pharmacoecon Out... 2026-07-00

Capivasertib was the first AKT inhibitor approved by the US FDA as a second-line treatment for PIK3CA/AKT1/PTEN-altered,...

Paracrine signals from HIV-1-infected immune cells reprogram cervical cancer ...

Olwal(CO),Rathore(U),Makanani(SK),Kaushal(... iScience 2026-06-19

...PIK3CA-activating mutations through IRS1-PI3K-AKT pathway activation. Our findings highlight IRS1 and the PI3K pathway a...

Inavolisib and lenvatinib for PIK3CA-mutated refractory splenic angiosarcoma:...

Zhao(X),Wang(C),Ge(Y),Song(D),Guan(A),Hu(J... Anticancer Drugs 2026-05-25

...PIK3CA p.P471L missense mutation. A combination regimen of inavolisib (a selective PI3Kα inhibitor) and lenvatinib was i...

上一页 21 22 23 24 25 26 27 28 29 下一页 25 / 共 350

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com